Rivkah Rogawski, Ph.D.

Rivkah Rogawski, Ph.D., is a scientist currently employed at Emendo Biotherapeutics since October 2021. Prior to this, they worked as a Postdoctoral Fellow at the Weizmann Institute of Science from September 2019 to October 2021, where they were awarded a Fulbright postdoctoral fellowship. Their research at the institute focused on combining cell biology and proteomics with cutting-edge structural mass spectrometry to investigate the 20S proteasome, along with methods development for structural mass spectrometry. Before their time at the Weizmann Institute of Science, Rivkah worked as a Postdoctoral Researcher at Columbia University in the City of New York from November 2017 to April 2019. Rivkah also served as a Graduate Student Researcher at Columbia University in the City of New York, specifically in the McDermott Lab, from September 2011 to November 2017.

Rivkah Rogawski, Ph.D. pursued their education in the field of Chemistry. Rivkah completed their Bachelor of Arts degree in Chemistry from Yeshiva University in 2011. Rivkah then went on to pursue their Ph.D. at Columbia University, GSAS, specializing in Chemistry. Rivkah successfully obtained their Ph.D. in 2017 from Columbia University.